| Patents for C07K - Peptides (3,738) |
|---|
| 04/26/2006 | CN1763122A Water-soluble polymer alkanals |
| 04/26/2006 | CN1253205C 疫苗 Vaccine |
| 04/19/2006 | EP1646652A2 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same |
| 04/19/2006 | EP1646352A2 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 04/18/2006 | USRE39071 Anhydro-and isomer-a-21978c cyclic peptides |
| 04/13/2006 | US20060078554 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 04/11/2006 | US7026524 Human coagulation factor VII variants |
| 04/06/2006 | US20060073576 envelope proteins (Env) comprising CD4 (and mimetics) binding site and deletion region; maintains structural conformation of complementary determining region 2-like loop; insertion near chemokine receptor binding site; vectors, cells; liposomes |
| 04/05/2006 | CN1249229C Soluble T cell receptor |
| 04/05/2006 | CN1249081C Glycopeptide derivatives and pharmaceutical compositions containing same |
| 03/30/2006 | WO2004094458A3 Major histocompatibility complex (mhc)-peptide arrays |
| 03/30/2006 | WO2004072103A3 Macromolecule identification made by mass spectrometry and database searching |
| 03/30/2006 | US20060067885 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell |
| 03/29/2006 | EP1638579A2 Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury |
| 03/23/2006 | WO2005040191A3 Ccn1 compositions and methods |
| 03/23/2006 | WO2005033125A3 Mammalian t1r3 sweet taste receptors |
| 03/23/2006 | WO2004016642A3 ISOFORM SPECIFIC INTERACTIONS OF APOLIPOPROTEIN E TO AN INTERMEDIATE CONFORMATION OF ALZHEIMER Aβ PEPTIDE |
| 03/22/2006 | EP1636251A2 Ccn1 compositions and methods |
| 03/22/2006 | EP1636250A2 Self-assembling peptides incorporating modifications and methods of use thereof |
| 03/22/2006 | EP1635879A2 Lectin conjugates |
| 03/22/2006 | EP1635855A2 Selective r-cadherin antagonists and methods |
| 03/22/2006 | EP1635846A2 Small molecule toll-like receptor (tlr) antagonists |
| 03/22/2006 | EP1597278A4 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 03/22/2006 | CN1751064A Hsp60 from arthrobacter |
| 03/22/2006 | CN1750842A Analogues of GLP-1 |
| 03/16/2006 | WO2004099231A3 Glycopegylation methods and proteins/peptides produced by the methods |
| 03/16/2006 | US20060057111 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/09/2006 | WO2006024694A2 Peptide inhibitors of hk2 and their use |
| 03/09/2006 | US20060051764 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 03/09/2006 | US20060051760 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 03/09/2006 | US20060051361 Vaccine against Streptococcus pneumoniae |
| 03/08/2006 | EP1632248A1 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 03/08/2006 | EP1631553A2 Capture and release based isotope tagged peptides and methods for using the same |
| 03/08/2006 | EP1631319A2 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/08/2006 | EP1631315A2 Antibodies which bind human cxcr3 |
| 03/08/2006 | CN1743456A Modulators of the function of receptors of the TNF/NGF receptor family and other protein |
| 03/07/2006 | US7008764 Optimization of cells for endogenous gene activation |
| 03/01/2006 | EP1629088A2 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 03/01/2006 | EP1629000A2 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | CN1740198A GLP-1 derivative |
| 02/23/2006 | WO2004074310A3 Mycobacterial diagnostics |
| 02/23/2006 | US20060040851 Gag-peptide complex |
| 02/23/2006 | US20060039906 Humanized antibodies that sequester abeta peptide |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/16/2006 | WO2006015882A2 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 02/16/2006 | WO2005056575A3 INTEGRIN αIIbβ3 SPECIFIC ANTIBODIES AND PEPTIDES |
| 02/16/2006 | WO2005056574A3 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 02/16/2006 | WO2004106359A3 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals |
| 02/16/2006 | US20060035377 Pathogen-resistant grape plants |
| 02/16/2006 | CA2575406A1 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 02/15/2006 | EP1625155A1 Novel antimicrobial peptides with heparin binding activity |
| 02/15/2006 | EP1625144A2 Polyvalent immunogen |
| 02/15/2006 | EP1624882A2 Compositions for delivering peptide yy and pyy agonists |
| 02/15/2006 | CN1733800A Outer surface proteins, their genes, and their use |
| 02/09/2006 | WO2005016953A3 Antagonistic analogs of gh-rh (2003) |
| 02/09/2006 | WO2004009616A3 Ghrelin analogs |
| 02/09/2006 | US20060030007 Peptides for metal ion affinity chromatography |
| 02/09/2006 | US20060029940 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 02/08/2006 | EP0694067B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 02/08/2006 | CN1732014A Templated native silk smectic gels |
| 02/08/2006 | CN1240718C Aggregates of human insulin derivatives |
| 02/07/2006 | US6995015 Pathogen-resistant grape plants |
| 02/02/2006 | WO2005021581A3 Inducers of plant disease resistance |
| 02/01/2006 | EP1620726A2 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 02/01/2006 | EP1620456A2 Hla-a2 tumor associated antigen peptides and compositions |
| 02/01/2006 | EP1115849B1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 02/01/2006 | CN1729018A G-CSF conjugates |
| 01/26/2006 | WO2004013160A3 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 01/26/2006 | US20060018919 Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines |
| 01/25/2006 | EP1618124A2 Prophylactic and therapeutic benefits of new class of immune stimulating peptides |
| 01/25/2006 | EP1617865A2 Enhanced hiv-1 vaccines and methods for their use |
| 01/19/2006 | WO2005056576A3 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/18/2006 | EP1616181A2 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 01/18/2006 | EP1616011A2 Chimeric polypeptides and their use |
| 01/18/2006 | EP1615996A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 01/18/2006 | EP1615948A2 Immuno-amplification |
| 01/18/2006 | EP1615945A2 Glycopegylation methods and proteins/peptides produced by the methods |
| 01/18/2006 | EP1615653A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/12/2006 | WO2005118613A3 Antibacterial amide macrocycles |
| 01/12/2006 | US20060008846 Methods are described for the screening and identification of antagonist for TGF- beta superfamily members, in particular activin-A antagonist; antagonism of TGF- beta receptors by variants of the TGF- beta superfamily of ligands |
| 01/11/2006 | EP1614426A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 01/11/2006 | EP1614140A2 Mass spectrometry data analysis techniques |
| 01/11/2006 | EP1613343A2 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 01/05/2006 | WO2006001771A1 Separation matrix and method of purification |
| 01/05/2006 | WO2005030793A3 Antibodies which bind human cxcr3 |
| 01/05/2006 | US20060003939 Stimulating or accelerating apoptosis by contacting cell with an (Inhibitor of Apoptosis Protein) IAPi-derived peptide having a Trp-box consensus sequence and an RHG amino acid consensus sequence; antitumor, anticarcinogenic and antiinflammatory agents; induces self-ubiquitination; drug screening |
| 01/05/2006 | CA2570624A1 Separation matrix and method of purification |
| 01/04/2006 | EP1611151A2 Stq-peptides |
| 01/04/2006 | EP1610805A2 Thiol-mediated drug attachment to targeting peptides |
| 01/04/2006 | EP1610774A2 Tie-2 modulators and methods of use |
| 01/04/2006 | CN1715413A Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 12/29/2005 | WO2005123775A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 12/29/2005 | WO2005123767A1 Peptide-based compounds |
| 12/29/2005 | WO2005056578A3 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 12/29/2005 | WO2005051974A3 Novel molecules for regulating cell death |